Female Viagra Seeking Approval For Third Time

Photo Credit: Flickr

Photo Credit: Flickr

On June 4, the FDA will discuss whether or not flibanserin, a drug more commonly known as “women’s Viagra”, should be approved to treat low sexual desire in women, according to New York Times. This will be the third time this discussion will be taking place. Supporters, mostly led by an effort called Even the Score, argue that this decision is based on gender equality, as women do not have the same resources as men when it comes to sexual dysfunction.

If the drug were to be approved, flibanserin would be the first drug to specifically address a low sex drive in women. There are 26 approved treatments similar to that cause for men, according to the Times. So far, the agency has denied approval for the drug, saying that its benefits don’t outweigh its potential side effects like nausea and dizziness. The meeting will be open to the public.

This entry was posted in Health and tagged , , . Bookmark the permalink.
You are not authorized to see this part
Please, insert a valid App IDotherwise your plugin won't work.

Leave a Reply

Your email address will not be published. Required fields are marked *